Tracking recovery from C. diff infection in hospital patients
Part of Infections clinical trials.
This study follows patients with Clostridioides difficile (C. diff) infection to see how their symptoms improve and when the bacteria clear from their body. It aims to better understand recovery and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently hospitalized at GH Paris Saint-Joseph
- You have a confirmed C. diff infection or a repeat infection
- You are starting treatment for C. diff
- You speak French and agree to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks people who receive a fecal microbiota transplant (FMT) for a serious or repeat C. diff infection. It helps doctors better understand how safe and effective FMT is in real-world use.
This study tracks a specific kind of antibiotic-resistant gut bacteria in hospital patients and how it may spread to people living in the same home. It may help researchers understand transmission risk inside households and improve prevention strategies.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This trial tests a new treatment called CMTS0929 for people with C. diff infection. It aims to see if the treatment can help clear the infection and improve symptoms.
This trial studies how Clostridioides difficile (C. diff) affects healthy people by intentionally giving a controlled dose. The goal is to understand the infection better and help develop future treatments or vaccines.
This study looks at levels of C. diff toxins in stool after standard antibiotic treatment. It aims to understand how toxins change during recovery, which may help improve future treatments for C. diff infections.
Hear when a new Clostridium Difficile Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.